MedTrace Logo

Randomized Population-Based Study on Chlamydia Trachomatis Screening

NCT00827970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30000

Last updated 2009-01-23

No results posted yet for this study

Summary

30,000 individuals living in Aarhus County, Denmark by Oct 1997 were randomized into two groups. The intervention group received an invitation to be tested for urogenital Chlamydia trachomatis by use of home-obtained and mailed sample (9,000 individuals). The control group received no intervention (21,000 individuals). Outcome measures: Number of tested individuals, number of detected infections, number of women developing PID, ectopic pregnancy or infertility, number of women giving birth to a child, number of women receiving IVF treatment and number of men developing epididymitis.

The hypothesis was that more individuals would be tested and treated for infections and that number of long term fertility complications would decline in the intervention group compared to control group.

Conditions

Interventions

BEHAVIORAL

Screening for urogenital Chlamydia trachomatis

Receeiving an invitation to be tested for urogenital Chlamydia trachomatis by use of a home-obtained and mailed sample.

Sponsors & Collaborators

  • Aarhus County, Denmark

    collaborator OTHER

  • Novo foundation

    collaborator UNKNOWN

  • The Danish Medical Research Council

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Berit Andersen, MD, Ph.D. · Aarhus University Hospital Skejby, Department of Infectious Diseases

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1997-10-31
Primary Completion
1998-02-28
Completion
2007-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00827970 on ClinicalTrials.gov